
David Ricks is Chair & CEO of Eli Lilly (LLY). Most of a public-company CEO’s on-paper wealth is their stake in that company — anchored here on the number you can verify.
Past cash compensation, sold shares, real estate, and other public holdings — estimable from records, but not exact.
Private company stakes, trusts, cash, debts, and undisclosed assets. Anyone publishing these as a single number is guessing.
| Company | Eli Lilly (LLY) |
| Title | Chair & CEO |
| Verified stake | $829M |
| Shares owned | 708,781 |
| Latest total pay | $37M breakdown → |
| Age | ~59 |
We take the shares David Ricks reports owning in their most recent SEC Form 4 and multiply by the latest share price. That gives a stake value you can check against the filing itself. Everything beyond that stake — real estate, private holdings, cash, past compensation — is estimated or simply not public, and we say so rather than roll it into one number.
David Ricks studied at Purdue University and earned an MBA from Indiana University, then spent his entire career at the drugmaker Eli Lilly. He worked across the company’s US and international businesses, running Lilly’s American operations and later its biomedicines division.
He became chairman and chief executive in 2017. His tenure has coincided with the rise of Lilly’s diabetes and weight-loss drugs, built on tirzepatide, which turned the company into one of the most valuable in the world and made it a leader in the obesity-drug era.
Ricks is a hired executive and long-tenured company insider. His Lilly stake came from accumulated compensation, which is what this page reflects.
Born 1967 · Purdue University (BS); Indiana University Kelley (MBA)
| Fiscal year | Total pay |
|---|---|
| 2025 | $37M |
The stake value is filing-derived and verifiable; any broader “net worth” is an estimate. Photo: Virginia Office of the Governor, CC BY 4.0 (Wikimedia Commons). Share counts are the latest reported on SEC filings and change as the executive trades; the price is the last close, so the stake value moves with the market. This is not an official or complete accounting of anyone’s wealth. Educational only — not investment advice.